Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm
复制标题
DOI：
10.1002/cyto.a.24009
复制
发表时间：
2020-07-01
期刊：
影响因子：
3.7
通讯作者：
Mussini, Cristina
中科院分区：
文献类型：
--
作者：
Cossarizza, Andrea;Gibellini, Lara;Mussini, Cristina
由严重急性呼吸系统综合征冠状病毒2引起的大流行严重影响了所有在实验室工作的人。来自已知感染患者或被认为健康的捐赠者的样本可以到达，同事可能没有症状，但能够传播病毒。在临床实验室工作带来了一些安全挑战。几年前，国际细胞计数促进协会发布了安全分析和分类人类样本的指南，这些指南在这些天进行了修订。我们描述了自意大利出现第一例患者以来我们一直遵循的程序，这些程序仅对我们的标准程序进行了轻微修改，因为所有人类样本都与风险相关。(c)2020年国际细胞计数促进学会
The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. (c) 2020 International Society for Advancement of Cytometry